
Foldikines™: Reprogramming the Immune System Like Software Code
Cytokines are the immune system’s messengers, sending signals to direct immune responses. But in many diseases, these signals go wrong, much like in a faulty software program that starts producing errors.
Orikine Bio’s Foldikine™ platform works by engineering cytokines that act like "patches" in a malfunctioning computer program, fixing the faulty signals and restoring the immune system to its proper function.
News and events

Join us
At Orikine Bio, we are pioneering the future of cytokine-based therapies, pushing the boundaries of science and biology to develop groundbreaking solutions for autoimmune and inflammatory diseases. Our success is driven by the passion, creativity, and scientific rigor of our team. If you are excited about joining a company at the forefront of biotechnology, where innovation meets impact, Orikine is the place for you.
Investors
Grants
Project CPP2023-010468 financed by MICIU/AEI/10.13039/501100011033; Project CPP2024-011392 financed by MICIU/AEI/10.13039/501100011033
PTQ2022-012499 awarded by MCIU/AEI / 10.13039/501100011033; PTQ2023-012951 awarded by MICIU/AEI / 10.13039/501100011033
Project SNEO-20241312 financed by Centro para el Desarrollo Tecnológico y la Innovación E.P.E. (CDTI) in the context of Plan Estatal de Investigación Científica y Técnica y de Innovación
This company is capitalized by INNVIERTE, AN INVESTMENT PROGRAM OF CDTI, E.P.E.
